Carregant...
Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany
BACKGROUND: Perioperative administration of ferric carboxymaltose (FCM) was previously shown to reduce both the need for transfusions and the hospital length of stay in patients with preoperative iron deficiency anemia (IDA). In this study, we estimated the economic consequences of perioperative adm...
Guardat en:
| Publicat a: | Risk Manag Healthc Policy |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5923254/ https://ncbi.nlm.nih.gov/pubmed/29731670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RMHP.S157379 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|